If you can see this message, your browser does not support canvas and needs an update. Sorry. :(
Thursday, August 22, 2019 
Market Status: OPEN
About us and Governance Investor Relations Contact
Advanced search

Market News

Med Life S.A. - M

MedLife acquires the majority stake in Rozsakert Medical Center, Hungary

Release Date: 1/30/2019 9:40:12 AM

IRIS Code: 2C71E



MedLife takes the first step outside the borders and acquires the majority stake in Rozsakert Medical Center, Hungary


Through this acquisition, MedLife consolidates its position and becomes one of the largest private healthcare providers in Central and Eastern Europe


Bucharest, January 30, 2019: MedLife, the leader of the private medical services market in Romania, crosses the country's border and announces the first international transaction: the acquisition of 51% of the Rozsakert Medical Center Group of companies in Hungary.


The Rozsakert Medical Center (RMC) is in top 10 providers of private medical services in Hungary. The group has a multidisciplinary clinic that is also equipped with a small surgery room and a dental center. According to the company's representatives, more than 40,000 patients use RMC services every year. They access a wide range of clinical and para-clinical outpatient services and investigations, as well as a complex range of day hospitalization interventions, focusing on the specialties of ophthalmology, gynecology, proctology, dermatology, plastic surgery, and more others.


The group of companies was set up in 2001 by Dr. Gyula Csermely, gynecologist-obstetrician, and after 18 years of operation, it brings together a team of over 250 doctors and nurses. They have developed continuously, having a very dynamic pace in recent years, and have managed to maintain the highest standards both medically and technologically.


In 2017 the group registered a turnover of 4.2 million euros, according to the management of RMC which consists of eight members (Dr. Gyula Csermely, Dr. Eszter Bodnar, Dr. Tibor Elekes, Dr. Kinga Jokay, Dr. Orsolya Gudor, Dr. Imre Bodo, Dr. Andor Hirschberg and economist Vilmos Benko).


"It is the first move outside Romania of a Romanian company operating in the private medical sector and we are proud that MedLife, the leader of the medical services market in Romania, exceeds the borders and leads the Romanian capital further. Hungary has an interesting, growing private medical market. I think that through our know-how in respect of expansions, as well as the good relationship with the existing shareholders of the companies already integrated in the Group, we will be able to develop a solid long-term partnership. The medical team in Hungary is very valuable and we believe that together we will strengthen the MedLife system to provide high-quality medical services to patients both in Romania and Hungary. The investments allocated for this stage amount to 4-5 million euros, and in the next period we will look at other expansion opportunities. Europe suffers in terms of cross-boarder businesses, until now very few companies have achieved this, especially in the complex medical field, with medical clinics, imaging, laboratories and hospitals under the same roof. We have the chance to provide an example, and to the extent we will succeed, Hungary and Romania can become pioneers of a regional Company" said Mihai Marcu, CEO and Chairman of MedLife Group.


"We were invited to Romania to see how MedLife group works and we were truly amazed at what we saw. We have been able to see how top medicine is practiced at international standards in an extremely well-organized manner. We returned home thinking that this is a group in which we would be happy to continue our path and development. That's how the negotiations began. The investment made is not just a transaction, it is also the incorporation of a well-capitalized strategic partner with a similar approach to ours. We will go further in the same direction, the strategic goal being expanding and accelerating growth, "said Dr. Gyula Csermely, CEO of RMC.


The local acquisition plan of MedLife Group continues in 2019 as well as the development of other business segments. "We have created a complex medical system with national coverage, there is no town of more than 200,000 inhabitants in which MedLife is not present. In 2019 we will focus on digitization, on second opinion at national level and on the development of centers of excellence at the level of the 10 hospital units, for more specialties such as neurosurgery, cardiac surgery, abdominal wall surgery, gynecology and sports traumatology. We have grown a lot in terms of the complexity of the medical act, and this recommends us not only as a business partner but also as a solid medical partner" concluded Mihai Marcu, President and CEO of MedLife Group.


MedLife consultants in the RMC transaction were Schoenherr, the team being coordinated by Zita Albert (Partner) Schoenherr Hungary.


About MedLife:

MedLife is the largest private medical operator in Romania. The company operates the largest network of clinics, one of the major networks of medical laboratories, multi and monodisciplinary hospitals and it has the largest client base for Health Prevention Packages at national level. Also, sales-wise, it is one of the major private healthcare companies in Central and Eastern Europe.


The stock issued by MedLife SA is accepted for trading on the spot regulated market, managed by the Bucharest Stock Exchange, under the Premium Category, trading symbol “M”.


The MedLife Group has a successful background regarding both organic and also acquisition growth. Since 2009 the company has opened or bought over 83 medical units. Its strong and experienced management team has been able to create and manage these growth opportunities, acquiring valuable experiences and knowledge, allowing it to find the best way for carrying on the expansion process successfully.






Information provided by IRIS, the news platform of the Bucharest Stock Exchange.


Bucharest Stock Exchange ("BVB") is not responsible for the content of this News item. Issuers whose financial instruments are traded on markets operated by BVB are required to report in accordance with current legal and regulatory provisions. BVB publishes these Reports as market administrator, appointed by ASF. When, for investors’ information, Reports are published, either signed by different persons, or with conflicting information, legal liability lies fully with the signatories. BVB disclaims any obligation or responsibility towards issuers or third parties, regarding the reality, completeness and accuracy of information provided by them and distributed by BVB. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.

©2016 Bucharest Stock Exchange. All rights reserved